Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Agilent Technologies Inc. (A:NYSE), powered by AI.
Agilent Technologies Inc. is currently trading at $128.34. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Agilent Technologies Inc. on Alpha Lenz.
Agilent Technologies Inc.'s P/E ratio is 28.0.
“Agilent Technologies Inc. trades at a P/E of 28.0 (premium valuation) with strong ROE of 20.6%. Operating margin of 21.3% indicates strong profitability.”
Ask for details →Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.
“Agilent Technologies Inc. trades at a P/E of 28.0 (premium valuation) with strong ROE of 20.6%. Operating margin of 21.3% indicates strong profitability.”
Ask for details →Agilent Technologies Inc. (ticker: A) is a company listed on NYSE in the Healthcare sector (Diagnostics & Research). It has approximately 18,000 employees. Market cap is $36.4B.
The current price is $128.34 with a P/E ratio of 27.97x and P/B of 5.41x.
ROE is 20.62% and operating margin is 21.29%. Annual revenue is $6.9B.